A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children.

PHASE3CompletedINTERVENTIONAL
Enrollment

320

Participants

Timeline

Start Date

September 30, 2004

Study Completion Date

January 31, 2007

Conditions
Hypertension
Interventions
DRUG

Eplerenone

Trial Locations (41)

Unknown

Pfizer Investigational Site, Little Rock

Pfizer Investigational Site, Beverly Hills

Pfizer Investigational Site, Inglewood

Pfizer Investigational Site, Los Angeles

Pfizer Investigational Site, Jacksonville

Pfizer Investigational Site, Miami

Pfizer Investigational Site, Augusta

Pfizer Investigational Site, Park Ridge

Pfizer Investigational Site, Louisville

Pfizer Investigational Site, Shreveport

Pfizer Investigational Site, Boston

Pfizer Investigational Site, Ann Arbor

Pfizer Investigational Site, Jackson

Pfizer Investigational Site, Tupelo

Pfizer Investigational Site, Livingston

Pfizer Investigational Site, Carrboro

Pfizer Investigational Site, Chapel Hill

Pfizer Investigational Site, Pittsboro

Pfizer Investigational Site, Cleveland

Pfizer Investigational Site, Columbus

Pfizer Investigational Site, Youngstown

Pfizer Investigational Site, Tulsa

Pfizer Investigational Site, Portland

Pfizer Investigational Site, Philadelphia

Pfizer Investigational Site, Memphis

Pfizer Investigational Site, Beaumont

Pfizer Investigational Site, Houston

Pfizer Investigational Site, Katy

Pfizer Investigational Site, Santo Domingo

Pfizer Investigational Site, Bangalore

Pfizer Investigational Site, Chennai

Pfizer Investigational Site, Moscow

Pfizer Investigational Site, Saint Petersburg

Pfizer Investigational Site, Smolensk

Pfizer Investigational Site, Capital Park

Pfizer Investigational Site, Johannesburg

Pfizer Investigational Site, Pretoria

Pfizer Investigational Site, Soweto

Pfizer Investigational Site, Polokwane

Pfizer Investigational Site, Parow

Pfizer Investigational Site, Cape Town

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00147589 - A Study to Evaluate the Efficacy and Safety of Eplerenone in the Treatment of Hypertension in Children. | Biotech Hunter | Biotech Hunter